AO GENERIUM clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

1. Notable

   Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055…Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 · Mucopolysaccharidosis Type II

   Primary completion pushed from Jun 2026 to Dec 20, 2027

   Also in this update: Enrollment closed, study ongoing

   AO GENERIUM·Phase 2/3· NCT05208281· Registry history of NCT05208281 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.